FDA issues guidance on excipients for anti-counterfeiting; API-maker Rhodes accused of hazardous waste violations;

> The FDA has issued final guidance for the use of chemical identifiers for anti-counterfeiting. Guidance

> API-maker Rhodes Technologies, accused by the U.S. Environmental Protection Agency of violating hazardous waste laws, could be fined more than $250,000. Story

> NovaSterilis has been granted U.S. Patent 8,012,414 B2, "Sterilization of Drugs Using Supercritical Carbon Dioxide Sterilant." Release

> Chiesi Farmaceutici Spain will upgrade its CRM system to the Mobile Intelligence SaaS CRM Solution from Cegedim Relationship Management. Release

> Maria Crowe, senior VP for global drug product manufacturing, is being promoted to succeed retiring, 36-year vet Frank Deane as president of manufacturing operations at Eli Lilly ($LLY). Release

> The Indian Ministry of Health has approved a proposal to put 2D barcodes and scratch-off labels on medicines as a means of fighting counterfeiting. Story

> DASGIP, a supplier of parallel benchtop bioreactor systems, has unveiled the DASware bioprocessing solution for management of bioprocessing data. Release

> Cardinal Health has gained exclusive rights to distribute MicroPhage's KeyPath MRSA/MSSA blood testing kits in the U.S. and Canada in exchange for operational funding to develop products based on the same testing technology. Story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.